Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy.

Miyajima K, Yanagisawa T, Fukuokaya W, Sakakibara R, Uchida N, Miszczyk M, Inoue S, Matsukawa A, Urabe F, Mori K, Fujita N, Narita S, Hatakeyama S, Habuchi T, Shariat SF, Kimura T, JHA Collaborative Group

Open source

DOI: 10.1111/iju.70646
Published: 2026 Sep
Container: International journal of urology : official journal of the Japanese Urological Association
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/iju.70646,
  title = {Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy.},
  author = {Miyajima K and Yanagisawa T and Fukuokaya W and Sakakibara R and Uchida N and Miszczyk M and Inoue S and Matsukawa A and Urabe F and Mori K and Fujita N and Narita S and Hatakeyama S and Habuchi T and Shariat SF and Kimura T and JHA Collaborative Group},
  year = {2026},
  journal = {International journal of urology : official journal of the Japanese Urological Association},
  doi = {10.1111/iju.70646},
  url = {https://doi.org/10.1111/iju.70646}
}

RIS

TY  - JOUR
TI  - Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy.
AU  - Miyajima K
AU  - Yanagisawa T
AU  - Fukuokaya W
AU  - Sakakibara R
AU  - Uchida N
AU  - Miszczyk M
AU  - Inoue S
AU  - Matsukawa A
AU  - Urabe F
AU  - Mori K
AU  - Fujita N
AU  - Narita S
AU  - Hatakeyama S
AU  - Habuchi T
AU  - Shariat SF
AU  - Kimura T
AU  - JHA Collaborative Group
PY  - 2026
JO  - International journal of urology : official journal of the Japanese Urological Association
DO  - 10.1111/iju.70646
UR  - https://doi.org/10.1111/iju.70646
ER  -

APA

K, M., T, Y., W, F., R, S., N, U., M, M., S, I., A, M., F, U., K, M., N, F., S, N., S, H., T, H., SF, S., T, K., & Group, J. C. (2026). Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy.. International journal of urology : official journal of the Japanese Urological Association. https://doi.org/10.1111/iju.70646

Source records

pubmed · retrieved 2026-09-24T21:42:08.616Z
europe-pmc · retrieved 2026-09-24T21:42:08.646Z